Source: Energy Investing News

Gordagen Pharmaceuticals: Gordagen Pharmaceuticals Attends ECRM and Makes Big Splash

BOCA RATON, FL-(Marketwired - July 21, 2016) - Gordagen Pharmaceuticals, a company dedicated to developing high-quality nutraceuticals and prescription medicines based on natural tocotrienols (T3), announced the company was successful in forging some important new connections for its nE1-Heart brand when it attended the 2016 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida.GordagenThe post Gordagen Pharmaceuticals Attends ECRM and Makes Big Splash appeared first on Investing News Network.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Glenn Tong's photo - Chairman & CEO of Gordagen Pharmaceuticals

Chairman & CEO

Glenn Tong

CEO Approval Rating

68/100

Read more